Publications by authors named "Anoop Mistry"

Claim this Profile
U
Understanding patient perceptions, knowledge, and experience of perioperative allergic reactions: a qualitative interview study.
Louise Savic, Anoop Mistry, Sinisa Savic, Gururaj Arumugakani, Rupert Pearse

Br J Anaesth· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment outcomes in patients with VEXAS syndrome: a retrospective cohort study.
Adam Al-Hakim, Roochi Trikha, Ei Ei Phyu Htut, Onima Chowdhury, Calman A MacLennan, Anoop Mistry

Lancet Rheumatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Inherited CD19 Deficiency Does Not Impair Plasma Cell Formation or Response to CXCL12.
Kieran Walker, Anoop Mistry, Christopher M Watson, Fatima Nadat, Eleanor O'Callaghan

J Clin Immunol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug challenge testing: a critical step in the investigation of neuromuscular blocking agent hypersensitivity.
Anna Littlejohns, Philip M Hopkins, Sinisa Savic, Anoop Mistry, Louise Savic

Br J Anaesth· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inherited CD19 Deficiency Does Not Impair Plasma Cell Formation or Response to CXCL12.
Kieran Walker, Anoop Mistry, Christopher M Watson, Fatima Nadat, Eleanor O'Callaghan

J Clin Immunol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of personalized omalizumab dosing for chronic spontaneous urticaria.
Sarah Denman, Helin Smith, Gururaj Arumugakani, Anoop Mistry, Sinisa Savic

Clin Exp Dermatol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Diagnosis and Clinical Management of Acquired Systemic Autoinflammatory Diseases.
Adam Al-Hakim, Anoop Mistry, Sinisa Savic

J Inflamm Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyper-IgM syndrome resulting from heterozygous AICDA variants: A European first?
Mark Kacar, Jennifer K Shrimpton, Miriam Jassam, Anoop Mistry, Gururaj Arumugakani

Scand J Immunol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucose-6-Phosphatase Catalytic Subunit 3 () Deficiency Associated With Autoinflammatory Complications.
Anoop Mistry, Thomas Scambler, David Parry, Mark Wood, Gabriela Barcenas-Morales

Front Immunol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoimmune-autoinflammatory rheumatoid arthritis overlaps: a rare but potentially important subgroup of diseases.
Sinisa Savic, Anoop Mistry, Anthony G Wilson, Gabriela Barcenas-Morales, Rainer Doffinger

RMD Open· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bialellic Mutations in Tetratricopeptide Repeat Domain 7A (TTC7A) Cause Common Variable Immunodeficiency-Like Phenotype with Enteropathy.
Dylan Lawless, Anoop Mistry, Philip M Wood, Jens Stahlschmidt, Gururaj Arumugakani

J Clin Immunol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-1 Blockade: An Update on Emerging Indications.
Anoop Mistry, Sinisa Savic, Jeroen C H van der Hilst

BioDrugs· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH.
Mohamed Osman, Anoop Mistry, Ada Keding, Rhian Gabe, Elizabeth Cook

PLoS Negl Trop Dis· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Case of SLC29A3 Spectrum Disorder-Unresponsive to Multiple Immunomodulatory Therapies.
Anoop Mistry, David Parry, Bipin Matthews, Philip Laws, Mark Goodfield

J Clin Immunol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis